Shingles Vaccine Shortages Result From High Demand

Shingrix, the vaccine approved last year to prevent shingles, has proved so popular that its maker, GlaxoSmithKline, has not been able to produce it quickly enough.

from NYT > Health https://ift.tt/2DvVYg1
via health&fitness